Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Evotec and Roche collaborate on protein-activity based biomarkers for use in oncology

June 29, 2011

Jevtana/prednisone combination approved in Canada for prostate cancer

June 29, 2011

Preliminary phase I data suggest safety/activity of RO-4987655 in advanced/metastatic solid tumors

June 29, 2011

RG-7112 advances through clinical development for cancer

June 29, 2011

NK-012 shows promising activity in phase II trial in sensitive relapsed SCLC

June 29, 2011

Arno Therapeutics reports interim phase II data on AR-67 in glioblastoma multiforme

June 28, 2011

FDA lifts clinical hold on phase II Cavatak trial in melanoma

June 28, 2011

Arch Cancer Therapeutics prepares new brain tumor-targeting peptides

June 28, 2011

First-in-human study reveals activity of RAF-265 in melanoma

June 28, 2011

First-in-human data disclosed on ONX-0912 in recurrent/refractory solid tumors

June 28, 2011

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026